SVB Leerink Research Analysts Increase Earnings Estimates for Exact Sciences Co. (NASDAQ:EXAS)
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) – SVB Leerink increased their Q2 2023 earnings per share estimates for Exact Sciences in a research note issued to investors on Tuesday, June 20th. SVB Leerink analyst P. Souda now anticipates that the medical research company will post earnings per share of ($0.50) for the quarter, up […]
Source: tickerreport.com